NOTICE RE: COVID-19

As Canada’s Global Life Sciences Venture, it is important that adMare shows leadership in response to the COVID-19 pandemic, and in best protecting the health and well-being of our pan-Canadian team, their families, and our partners. As such, we have concluded, consistent with our values as an organization, that it is appropriate to implement some temporary measures to reduce the risk of contact and transmission while health authorities work to bring COVID-19 under control. Please note that effective March 11, as is feasible, adMare’s employees have been mandated to work from home, avoid non-essential business travel, hold virtual rather than in-person meetings, and not participate in large meetings or conferences. We remain committed to fully meeting our timelines and commitments as an organization, but you may see some changes in how we go about executing this work. We will provide regular updates in regard to these policies, and thank all our partners and stakeholders for your ongoing support during this challenging time.

WHO WE ARE

adMare BioInnovations is Canada’s Global Life Sciences Venture, building the Canadian life sciences industry from sea to sea. We do this by sourcing therapeutically and commercially promising research from leading academic and biotech partners to create new companies of scale, providing specialized expertise and infrastructure to help existing companies scale up, and driving the growth of those companies into Canadian anchors by training the next generation of highly-qualified personnel.